228 Results
Don’t Be Fazed by Phased Awards
Funding News Edition: December 20, 2023
Submitted applications contain plans for two phases of research, including milestones that the applicant believes will justify continued support into the second phase.
Develop 3D Organotypic Culture Models for Transplantation Immunology Research
Funding News Edition: December 20, 2023
3D organotypic culture models offer improved modeling of tissue architecture, cell-cell interactions, and other microenvironmental aspects of tissues and organ systems.
Participate in Research Education Program to Support a Diverse Workforce
Funding News Edition: December 20, 2023
Through courses for skills development and mentoring activities, NIAID strives to support current and future research investigators from diverse backgrounds.
Don’t Overlook an Opportunity for Intramural Collaboration
Funding News Edition: December 20, 2023
NIAID invites applications from actively-funded grant recipients to travel to NIAID laboratories for a short duration to perform research in partnership with a host intramural research investigator.
Find Funding for Ethical, Legal, and Social Implications Research
Funding News Edition: December 20, 2023
NIH seeks research projects studying the ethical, legal, and social implications of human genetic or genomic research, including empirical qualitative and quantitative methods.
Applicants—Before You Copy/Paste, Consider NIH’s Latest Case Study
Funding News Edition: December 20, 2023
Peer reviewers are prohibited from using and sharing materials from a confidential peer review meeting, and doing so constitutes a serious breach of confidentiality.
News Briefs and Worth Repeating
Funding News Edition: December 20, 2023
Subawards Policy Changes Take Effect on January 1, 2024; NIH Is Currently Operating Under a Continuing Resolution; Podcast Episodes Discuss the Hidden Curriculum for Early-Career Researchers
Distinguish Between Delayed Start and Delayed Onset in Human Subjects Research
Funding News Edition: December 20, 2023
If you are planning a delayed start to a human subjects study but wrongly mark it as a delayed onset study, your application will be missing important details which may negatively affect your score.
“If I submit two distinct R01 applications, and my percent effort on each exceeds 50 percent, what happens?”
Funding News Edition: December 20, 2023
If both applications are funded, we'll adjust your effort to be no more than 100 percent total when we negotiate your awards.
“What are NIAID’s expectations for a principal investigator approaching retirement?”
Funding News Edition: December 20, 2023
Your institution needs to seek and receive NIAID’s prior approval any time a principal investigator will reduce effort by 25 percent or more or be absent for 3 or more consecutive months.
NIH or NIAID? Know the Difference
Funding News Edition: December 6, 2023
NIH is made up of 27 institutes and centers, each with a specific research agenda, often focusing on particular diseases or body systems.
Develop Anti-Infective Strategies Against Viral, Bacterial, Parasitic, and Fungal Pathogens
Funding News Edition: December 6, 2023
NIAID seeks research projects to discover and develop compounds that promote targeted protein degradation of viral, bacterial, parasitic, or fungal pathogen components, as well as non-protein targets.
Study Long-Acting Drug Delivery Systems for ART Optimization in Children with HIV-1
Funding News Edition: December 6, 2023
This initiative will stimulate the optimization and evaluation of long-acting drug delivery systems formulations in suitable preclinical animal models at an earlier age of adult drug development.
Engineer Innovative Products to Kill HIV-Infected Cells
Funding News Edition: December 6, 2023
NIAID will fund research on late-stage engineering and preclinical development of innovative biological products that safely and specifically engage the immune system to kill HIV-infected cells.
Support for Development of Promising MCMs for Radiation Injuries
Funding News Edition: December 6, 2023
Apply to conduct mid-stage research developing candidate medical countermeasures (MCMs) already demonstrating efficacy to mitigate or treat radiation injuries.
Update on Foreign Disclosure and Risk Management of Small Business Awards
Funding News Edition: December 6, 2023
NIH SEED has useful foreign risk case studies to demonstrate instances in which foreign involvement does or does not generate security risks.
News Briefs and Worth Repeating
Funding News Edition: December 6, 2023
Dr. Monica Bertagnolli Is the New NIH Director; Attend Webinar for DEIA Excellence Supplemental Awards; Prepare Now for Upcoming Opportunity on Systems Modeling; Register for Native American Health Research Webinar on January 25; Monthly Automated Reminders for Rejected Final FFRs
Before a Collaboration Goes Awry, Have a Plan in Place
Funding News Edition: December 6, 2023
Even successful partnerships experience disagreements and disputes. To ensure those moments don’t derail your science, you need to have an established conflict resolution plan.
“When is the next NIH Advisory Committee to the Director meeting?”
Funding News Edition: December 6, 2023
Find the Right Person to Help You with General Inquiries
Funding News Edition: November 8, 2023
Whom should you ask for help with general matters like identifying an appropriate funding opportunity or discovering available resources?
“Will the new peer review criteria impact applications due on or after January 25, 2024?”
Funding News Edition: November 8, 2023
No, the implementation date for NIH’s Simplified Peer Review Framework is January 25, 2025—so, about 15 months from now, not 10 weeks. Later next year, NIH will reissue notices of funding opportunity to reflect the simplified review criteria and provide updated resources to applicants and reviewers.Learn more by watching the Online Briefing on NIH's Simplified Peer Review Framework for NIH
Promptly Determine Whether You’re Eligible to Apply
Funding News Edition: November 8, 2023
While a notice of special interest (NOSI) may stipulate eligibility criteria within its Purpose section, most NOSIs defer to the instructions listed in the identified notices of funding opportunities.
Conduct Multidisciplinary Research on Hepatitis B Cure in Persons Living with HIV and HBV
Funding News Edition: November 8, 2023
Research the impact of host and viral heterogeneity on pathogenesis of disease, viral persistence, and immunopathology of Hepatitis B virus (HBV) and inform cure strategies for HBV in people living with HIV.
Contact Us
Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.